APA (7th ed.) Citation

Guilhot, F., & Hehlmann, R. (2025). Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia: Reflections on a quarter century of TKIs in CML : review series. Blood, 145(9), . https://doi.org/10.1182/blood.2024026311

Chicago Style (17th ed.) Citation

Guilhot, François, and Rüdiger Hehlmann. "Long-term Outcomes of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Reflections on a Quarter Century of TKIs in CML : Review Series." Blood 145, no. 9 (2025). https://doi.org/10.1182/blood.2024026311.

MLA (9th ed.) Citation

Guilhot, François, and Rüdiger Hehlmann. "Long-term Outcomes of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Reflections on a Quarter Century of TKIs in CML : Review Series." Blood, vol. 145, no. 9, 2025, https://doi.org/10.1182/blood.2024026311.